| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.9M | +82.3% |
| R&D Expense | $89.5M | +54.0% |
| SG&A Expense | $23.9M | +19.2% |
| Operating Income | -$62.5M | -24.3% |
| Income Tax | $0 | — |
| Net Income | -$58.7M | -17.9% |
| EPS (Basic) | -$1.42 | -0.7% |
| EPS (Diluted) | -$1.42 | -0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.6M | -25.4% |
| Short-term Investments | $296.2M | +91.4% |
| Accounts Receivable | $211K | -80.9% |
| Current Assets | $370.5M | +47.6% |
| Total Assets | $388.0M | +1.7% |
| Current Liabilities | $31.7M | -29.8% |
| Total Liabilities | $38.5M | -51.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.2M | -56.3% |
| Capital Expenditures | $3.4M | +30.2% |
| Investing Cash Flow | -$33.4M | +52.1% |
| Financing Cash Flow | $97.2M | -33.2% |
| Free Cash Flow | -$90.6M | -55.1% |
| Stockholders' Equity |
| $349.5M |
| +15.9% |